Fibroma of prostate

Summary

Fibroma of prostate (MONDO:0021532) is a disease. A subtype of fibroma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	fibroma of prostate
Mondo ID	MONDO:0021532
NCIT	C3972
SNOMED CT	47014000
UMLS	C0268885
MedGen	75709
Anatomy (UBERON)	UBERON:0002367
Is cancer (heuristic)	no

Also known as: fibroma of the prostate · prostate fibroma · prostate gland fibroma

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › mesenchymal cell neoplasm › fibroblastic neoplasm › fibroma › fibroma of prostate

Related subtypes (10): testicular fibroma, liver solitary fibrous tumor, serous cystadenofibroma, adenofibroma, tendon sheath fibroma, uterine corpus leiomyoma, ovarian fibroma, calcified aponeurotic fibroma, fibroma of lung, oral fibroma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.